PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024
PolyPid (Nasdaq: PYPD), a late-stage biopharma company focused on improving surgical outcomes, has scheduled its third quarter 2024 financial results announcement for November 13, 2024, before U.S. markets open. The company will host a conference call and webcast at 8:30 AM Eastern Time to discuss results and provide business updates. Interested parties can register for the call through the provided link, with registration recommended at least 5 minutes before the start time. For those not planning to ask questions, the company suggests following via webcast.
PolyPid (Nasdaq: PYPD), una compagnia biofarmaceutica in fase avanzata, focalizzata sul miglioramento dei risultati chirurgici, ha programmato l'annuncio dei suoi risultati finanziari del terzo trimestre 2024 per il 13 novembre 2024, prima dell'apertura dei mercati statunitensi. L'azienda terrà una conferenza telefonica e una trasmissione in diretta alle 8:30 AM Eastern Time per discutere i risultati e fornire aggiornamenti aziendali. Le parti interessate possono registrarsi per la chiamata tramite il link fornito, con registrazione consigliata almeno 5 minuti prima dell'orario d'inizio. Per coloro che non intendono porre domande, l'azienda consiglia di seguire la trasmissione in diretta.
PolyPid (Nasdaq: PYPD), una empresa biofarmacéutica en fase avanzada enfocada en mejorar los resultados quirúrgicos, ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el 13 de noviembre de 2024, antes de la apertura de los mercados en EE. UU. La compañía llevará a cabo una conferencia telefónica y una transmisión por webcast a las 8:30 AM Eastern Time para discutir los resultados y proporcionar actualizaciones comerciales. Las partes interesadas pueden registrarse para la llamada a través del enlace proporcionado, con inscripción recomendada al menos 5 minutos antes de la hora de inicio. Para aquellos que no planean hacer preguntas, la compañía sugiere seguir a través del webcast.
PolyPid (Nasdaq: PYPD), 수술 결과 개선에 집중하는 말기 생명공학 회사가 2024년 3분기 재무 결과 발표를 2024년 11월 13일, 미국 시장 개장 전에 일정으로 잡았습니다. 회사는 동부 표준시 기준 오전 8시 30분에 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 전화 회의와 웹캐스트를 개최합니다. 관심 있는 분들은 제공된 링크를 통해 전화 회의에 등록할 수 있으며, 시작 시간보다 최소 5분 전에 등록하는 것이 권장됩니다. 질문할 계획이 없는 분들은 웹캐스트를 통해 청취하는 것을 권장합니다.
PolyPid (Nasdaq: PYPD), une entreprise biopharmaceutique en phase avancée axée sur l'amélioration des résultats chirurgicaux, a programmé l'annonce de ses résultats financiers du troisième trimestre 2024 pour le 13 novembre 2024, avant l'ouverture des marchés américains. L'entreprise organisera une conférence téléphonique et un webinaire à 8h30 HNE pour discuter des résultats et fournir des mises à jour commerciales. Les parties intéressées peuvent s'inscrire à l'appel via le lien fourni, avec une inscription recommandée au moins 5 minutes avant l'heure de début. Pour ceux qui ne prévoient pas de poser des questions, l'entreprise suggère de suivre via le webinaire.
PolyPid (Nasdaq: PYPD), ein biopharmazeutisches Unternehmen in der späten Phase, das sich auf die Verbesserung chirurgischer Ergebnisse konzentriert, hat die Bekanntgabe seiner Finanzergebnisse für das dritte Quartal 2024 für den 13. November 2024 vor der Eröffnung der US-Märkte angesetzt. Das Unternehmen wird um 8:30 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen und Unternehmensaktualisierungen bereitzustellen. Interessierte können sich über den bereitgestellten Link für den Anruf registrieren, wobei eine Registrierung mindestens 5 Minuten vor Beginn empfohlen wird. Für diejenigen, die keine Fragen stellen möchten, empfiehlt das Unternehmen, den Webcast zu verfolgen.
- None.
- None.
PETACH TIKVA, Israel, Oct. 30, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its third quarter 2024 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, November 13, 2024. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.
To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the webcast.
Conference Call Dial-In & Webcast Information:
| Date: | Wednesday, November 13, 2024 |
| Time: | 8:30 AM Eastern Time |
| Conference Call: | https://register.vevent.com/register/BI198de55d5c06495994d35cbb213655eb |
| Webcast: | https://edge.media-server.com/mmc/p/j6bnvt8c |
About PolyPid
PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional Company information, please visit http://www.polypid.com and follow us on Twitter and LinkedIn.
References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. PolyPid is not responsible for the contents of third-party websites.
Contacts:
PolyPid Ltd.
Ori Warshavsky
COO – US
908-858-5995
IR@Polypid.com
Investors:
Brian Ritchie
LifeSci Advisors
212-915-2578
Britchie@lifesciadvisors.com
FAQ
When will PolyPid (PYPD) release Q3 2024 earnings?
What time is PolyPid's (PYPD) Q3 2024 earnings call?
How can I join PolyPid's (PYPD) Q3 2024 earnings call?
